Yuan Q. Chang
Building 13, No. 130, Dongan Road
Shanghai, 200032, China
Shanghai, 200032, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 82 publications
Aberrant p53 fuels macrophage immunoregulatory polarization and refractory clinical outcome in urothelial carcinoma.
Journal: Journal for immunotherapy of cancer
Published: May 05, 2026
Proliferative ecotype determines lethal prognosis and therapeutic benefit in urothelial carcinoma.
Journal: Cancer
Published: February 10, 2026
Inulin enhances transglutaminase-induced peanut protein gel:Insights into gel and structural properties.
Journal: International journal of biological macromolecules
Published: November 11, 2025
Difructose anhydrides from inulin enhance cognitive function via gut microbiota modulation and synaptic signaling in mice.
Journal: Food research international (Ottawa, Ont.)
Published: October 24, 2025
Lethal clinical outcome and immuno-fibrotic contexture in refractory urothelial carcinoma harboring MYC amplification and overexpression.
Journal: British journal of cancer
Published: October 16, 2025
TP53 mutation-biased CD8+ T cell exhaustion drives lethal outcome and therapy resistance in urothelial carcinoma.
Journal: British journal of cancer
Published: July 24, 2025
Molecular mechanisms of Cornua Cervi Degelatinatum extract in promoting skin wound healing: Insights from transcriptomics and multi-model validation.
Journal: Journal of ethnopharmacology
Published: June 25, 2025
ARID1A Loss plus CD8+ T-Cell Infiltration Associate with Favorable Clinical Outcomes in Urothelial Carcinoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 06, 2025
Molecular features and cell composition of left-dominant arrhythmogenic cardiomyopathy reveals key pathways and therapeutic targets.
Journal: Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology
Published: December 23, 2024
Lethal clinical outcome and chemotherapy and immunotherapy resistance in patients with urothelial carcinoma with MDM2 amplification or overexpression.
Journal: Journal for immunotherapy of cancer
Published: December 13, 2024
CXCR6 expression predicts prognosis and immunotherapeutic benefit in muscle-invasive bladder cancer.
CXCR6 expression predicts prognosis and immunotherapeutic benefit in muscle-invasive bladder cancer.
Journal: Frontiers in oncology
Published: September 19, 2024
Last Updated: 09/26/2026